Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Eos Energy Enterprises
EOSE
$1.22B
| $2.21M | ﹤0.01% |
293,958
+10,306
| +4% | +$105K |
|
2677
Greif Class B
GEF.B
$4.11B
| $2.2M | ﹤0.01% |
36,817
-305
| -0.8% | -$19.6K |
|
|
LOVE
2678
DELISTED
LoveSac
LOVE
| $2.2M | ﹤0.01% |
33,171
+842
| +3% | +$61.7K |
|
2679
Erasca
ERAS
$6.3B
| $2.19M | ﹤0.01% |
140,526
+7,131
| +5% | +$122K |
|
|
SMLR
2680
DELISTED
Semler Scientific
SMLR
| $2.19M | ﹤0.01% |
+23,874
| New | +$2.68M |
|
2681
Pliant Therapeutics
PLRX
$64.4M
| $2.19M | ﹤0.01% |
161,988
+3,827
| +2% | +$60.8K |
|
2682
Gevo
GEVO
$360M
| $2.18M | ﹤0.01% |
508,458
+15,913
| +3% | +$97.5K |
|
|
LTRPA
2683
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $2.17M | ﹤0.01% |
999,538
+105,752
| +12% | +$299K |
|
|
LGTY
2684
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $2.16M | ﹤0.01% |
82,452
+3,602
| +5% | +$95.8K |
|
|
STER
2685
DELISTED
Sterling Check Corp. Common Stock
STER
| $2.15M | ﹤0.01% |
+105,031
| New | +$2.48M |
|
2686
PagSeguro Digital
PAGS
$2.69B
| $2.15M | ﹤0.01% |
82,127
+36,572
| +80% | +$1.19M |
|
2687
Caribou Biosciences
CRBU
$145M
| $2.15M | ﹤0.01% |
142,516
+9,239
| +7% | +$180K |
|
2688
Edgewise Therapeutics
EWTX
$4.13B
| $2.15M | ﹤0.01% |
140,395
+56,285
| +67% | +$1.01M |
|
|
RJET
2689
Republic Airways Holdings
RJET
$967M
| $2.14M | ﹤0.01% |
25,479
-272
| -1% | -$29.6K |
|
2690
Humacyte
HUMA
$176M
| $2.13M | ﹤0.01% |
+294,240
| New | +$2.91M |
|
2691
MaxCyte
MXCT
$112M
| $2.12M | ﹤0.01% |
207,822
+173,485
| +505% | +$1.86M |
|
2692
Digi International
DGII
$2.63B
| $2.12M | ﹤0.01% |
86,040
+1,490
| +2% | +$34.1K |
|
2693
Atlassian
TEAM
$25.6B
| $2.1M | ﹤0.01% |
5,513
-107
| -2% | -$43K |
|
|
NPTN
2694
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.08M | ﹤0.01% |
135,276
+3,449
| +3% | +$45.4K |
|
2695
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $2.08M | ﹤0.01% |
72,243
+942
| +1% | +$27.2K |
|
|
CYXT
2696
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $2.07M | ﹤0.01% |
163,926
+3,036
| +2% | +$30.9K |
|
2697
Alphatec Holdings
ATEC
$1.46B
| $2.07M | ﹤0.01% |
180,703
+3,103
| +2% | +$36.6K |
|
|
RRD
2698
DELISTED
RR Donnelley & Sons Co.
RRD
| $2.07M | ﹤0.01% |
183,438
| – | – |
|
|
DIDI
2699
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $2.06M | ﹤0.01% |
414,552
-10,602
| -2% | -$80.5K |
|
2700
Clear Secure
YOU
$5.57B
| $2.06M | ﹤0.01% |
65,498
+1,106
| +2% | +$40.9K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.